Adelaide, South Australia wants to let the secret out, and be known as hub for medical devices, pharmaceuticals, biotechnology, and digital health. It boasts world-class research institutions, such as the University of Adelaide and SAHMRI, fostering innovation and collaboration. The city’s supportive government policies provide incentives, grants, and streamlined regulations for businesses. Adelaide’s skilled workforce, renowned for its expertise in health sciences, offers a talent pool to drive industry growth. Additionally, the city’s strategic location, advanced infrastructure, and strong healthcare ecosystem make it an ideal base for development, manufacturing, and market access, attracting companies in these sectors.
Australian Health Journal spoke to Jo Close, heading the Adelaide arm of MTPConnect about the opportunity its building through its role as the industry growth centre, to help increase commercialisation and collaboration across the sector, optimise the regulatory environment, improving workforce skills and access to markets globally.
One of the companies showing world leading MedTech capabilities arising from Adelaide is Additive Surgical, the first company in Australia to manufacture 3D Printed Titanium novel spinal implant technologies. Its mission is to manufacture the highest quality medical technology in Australia that positively impact the lives of people globally.
Australian Health Journal met with Co-founder and CEO Gibran Maher.
Maher states, “Additive Surgical is committed to supporting Australian innovation and works closely with the Australian clinicians, hospitals, research institutions and universities to innovate and manufacture locally.”
Maher points out the ability to compete is made possible through supportive collaboration with government, research and other enterprises seeking to learn from each other. But to truely compete in international markets, Australia’s needs to further strengthen its sovereign capability.
Currently Australia imports more than 80% of its medical devices. Large multinational companies have very strong market share in Australia and the profits from these companies are largely returned to their international shareholders.
Additive Surgical is committed to manufacturing in Australia, developing intellectual property in Australia and supporting Australian innovation and commercialisation.
-
Trends report identifies prototyping targets for breakthroughs in digital and hybrid futures
Vishaal Kishore, a Professor of Innovation and Public Policy at RMIT in Melbourne, serves as the Executive Chair of the RMIT-Cisco Health Transformation Lab and RMIT’s Director of Impact. Led by the RMIT-Cisco Health Transformation Lab, the National Industry Innovation Network (NIIN) Health Alliance combines the best minds, technologists, industry capabilities and academic resources to solve pressing industry and social challenges through technology-driven innovation. The NIIN aims to pool insights and expertise to address national health challenges, marking its first vertical focus on health.
-
Report: Youth pathways to health services
The 2020 Youth Health Forum (YHF) was created to make young people’s ideas and experiences part of our national discussions about services for young Australians.
Healthcare professionals across Australia have long recognised the problem of young people falling through the gaps of a health system that wasn’t designed for them.
-
Practising to top scope of urology practice, advancing treatment & patient care through research
Michael is a urology nurse practitioner with a special interest in prostate cancer survivorship, and has worked in urology for the past ten years. Michael has completed the Prostate Nursing Care course at Latrobe University, Graduate Certificate of Health with a specialisation in Scheduled Medicines (USQ), and the Master of Nursing (Flinders) to become a Nurse Practitioner in 2024.
As a Urology Nurse Practitioner he divides his time between the Australian Prostate Centre and Western Urology.
